Treatment and diagnosis of severe KPC-producing <i>Klebsiella pneumoniae</i> infections: a perspective on what has changed over last decades-Reference-Cited by-同舟云学术

Treatment and diagnosis of severe KPC-producing Klebsiella pneumoniae infections: a perspective on what has changed over last decades

Published:2023-03 Issue:1 Volume:55 Page:101-113
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Giacobbe Daniele Roberto¹²^ORCID,Di Pilato Vincenzo³^ORCID,Karaiskos Ilias⁴^ORCID,Giani Tommaso⁵⁶^ORCID,Marchese Anna³⁷,Rossolini Gian Maria⁵⁶^ORCID,Bassetti Matteo¹²^ORCID

Affiliation:

1. Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy

2. UO Clinica Malattie Infettive, IRCCS Ospedale Policlinico San Martino, Genoa, Italy

3. Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Genoa, Italy

4. First Department of Internal Medicine – Infectious Diseases, Hygeia General Hospital, Athens, Greece

5. Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

6. Clinical Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy

7. UO Microbiologia, IRCCS Ospedale Policlinico San Martino, Genoa, Italy

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2022.2152484

Reference85 articles.

1. Tackling the threat of antimicrobial resistance: from policy to sustainable action

2. Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention

3. Recent advances in the pharmacological management of infections due to multidrug-resistant Gram-negative bacteria

4. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

5. Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carbapenem-resistant Klebsiella pneumoniae : the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge;Expert Review of Anti-infective Therapy;2024-01-18

2. Functional features of KPC-109, a novel 270-loop KPC-3 mutant mediating resistance to avibactam-based β-lactamase inhibitor combinations and cefiderocol;International Journal of Antimicrobial Agents;2024-01

3. The Etiology, Antibiotic Therapy and Outcomes of Bacteremic Skin and Soft-Tissue Infections in Onco-Hematological Patients;Antibiotics;2023-12-13

4. Case series; Ceftazidime/avibactam for treating post-neurosurgical ventriculitis and meningitis due to Carbapenem-resistant Klebsiella pneumonia (CRKP);Interdisciplinary Neurosurgery;2023-12

5. Mutations in ompK36 differentially impact in vitro synergy of meropenem/vaborbactam and ceftazidime/avibactam in combination with other antibiotics against KPC-producing Klebsiella pneumoniae;JAC-Antimicrobial Resistance;2023-09-04